Qube Research & Technologies »

Kintara Therapeutics shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Kintara Therapeutics (KTRA) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Kintara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kintara Therapeutics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kintara Therapeutics by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $685 6.6k 0.10

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding Kintara Therapeutics

UBS Group
Susquehanna International
Hrt Financial
Jane Street
Geode Capital Management
Tower Research Capital
Nantahala Capital Management
Vanguard Group
State Street Corporation
Qube Research & Technologies
Advisor Group Holdings
Acadian Asset Management
Wells Fargo & Company

View all funds holding Kintara Therapeutics